Autoimmune haematology Flashcards

1
Q

How do platelets form part of hte innate immune system

A

roll around epithelium and are one of the first barrriers to infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the type of apoptosis seen with a high antigen laod?

A

extrinsic pathway and active apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the type of apoptosis seen when there is a low antigen load?

A

intrinsic pathway and passive apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does impaired fas function contribute to autoimmunity?

A

unchekced expansion of autoreactive lymphocytes—antibody and T cell mediated autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does overactive fas function contribute to autoimmunity?

A

excessive Fas mediated killing in target tissues—cytotoxic cell mediated autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many patients with autoimmune disease have a Fas mutation approximately?

A

<1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the different actions of antibody that can lead to AI haematology disease?

A

neutralisation of clotting factor; inhibition of enzyme actiivty; coating of cells and activation of macrophages FcR medaited premature destruction of cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common AI haematology disease?

A

immune thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 2 methods of developing antibody to factor VIII?

A

if have haemophilia A- given synthetic FVIII from young age can develop antibodies or if given when have activated immune system; acquired due to infection or malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathogenesis of thrombotic thrombocytopenic purpura?

A

antibody prevents ADAMTS13 from cleaving von willebrand factor which is very sticky for platelets resulting in microthrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the overall pathogenesis of immune thrombocytopenia?

A

antiplatelet antibodies coat plaelets which reacts with Fc on macropahges who remove the platelts and megakaryocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the result of untreated TTP?

A

80% mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of antibody mediates ITP?

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What would happen if ITP was mediated by IgM?

A

rather than activating Fc receptor would activate complelent leading to lysis of the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In how many patients are autoantibodies detected in ITP?

A

60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why might only 60% have detectable antibodies in ITP?

A

difficult to detect them; T cell mediated disease as well; maybe IgM so compleemnt lyses immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why do you get petechiae with ITP?

A

platelets arent/ coating the vessels maing them leakier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the most common antibody found in ITP?

A

anti-glycoprotein IIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What suggests that FOXP3 cells are dysregulated in ITP?

A

IPEX patients get ITP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What indicates that megakaryoctes are suppressed in ITP?

A

compared with controls, produce variably less megakaryocytes, when remove antibodies from serum, improves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are hte T cell abnormalities seen in ITP?

A

increased Th1 in chronic ITP; decreased Th2 and decreased numbers of FOXP3 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What studies show the role of increased proliferation of T cells in ITP?

A

increased thymidine incorporation (marker of T cell prolfieration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How are megakaryoctes affected in ITP?

A

antibodies bind to bone marrow megakaryocytes impairing their maturation and platelt production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the mechanisms of rituximab mediated cytotoxicity?

A

apoptosis; inhibition of proliferation; complement-mediated lysis or phagocytosis; cell-mediated cytotoxicity; enhancement of the susceptibility to chemotherapy-induced cytotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Which cells don't express CD20?
plasma cells and pre-pre B cells
26
How many patients with ITP respond to rituximab
50%
27
What is given along with rituximab?
dexamethasone- helps destroy plasma cells not targeted by rituximab and helps prevents anti-mouse antibodies
28
What is one of hte advantages of giving rituximab treatment?
it patients have a good response to rituximab, its effects tend to last for years
29
What is the effect of rituximab on T cells?
corrects the Th1/Th2 ratio in responders ; imrpvoes Treg numbers
30
What infection is a problem with rituximab?
reactivation of hep B - avoid in acitve disease or give antivirals
31
Why should vaccines been given before rituximab therapy?
reduces vaccine responses
32
How can rituximab affect b cells in the long-term with repeated courses?
a late rare complication is hypogammaglobulinaemia
33
Waht are hte 3 general treatment options for antibodies against FVIII?
overwhelm the inhibitor; bypass the inhibitor and remove the inhibitor
34
How can you overwhelm the inhibitor in FVIII disease?
high dose human plasma dervied FVIII or porcine FVIII
35
How can the inhibitor in FVIII be bypassed?
recombinant acgitvated coag factor VII; prothrombin complex concentrates
36
How can the inhibitor be removed in FVIII disease?
exchange plasmapheresis; desmopressin; IVIgG
37
How has rituximab be used in FVIII inhibitors?
was used in 4 patients who all responded
38
How does dexamethasone affect the Th1/Th2 balance?
decreases the Th1/Th2 ratio; increases Tregs
39
What pre-medication should anti-D be given with?
steroids; paracetamol and antihistamine
40
How does anti-D therapy work in ITP?
if coat the RBCs with antibody, then macrophage is overwhlemed and destroys the RBCs instead of hte platelets
41
What type of patietns with ITP don't respond to rituximab?
immunodeficient patietns
42
How does IVIgG work in ITP?
FcR blockade; immune modulation--decreased phagocytosis of platelts
43
What is the MOA of MMF?
reversibly inhibits inosine monophosphate dehydrogenase= which controls purine synthesis used in the proliferation of B and T cells
44
Who can MMF not be used in?
pregnancy
45
What are some of the issues with MMF?
fatal infeciton; PML; shingles
46
What treatment offers the best chance for clinical remission with ITP?
splenectomy
47
What % of patients remain refractory after splenectomy with ITP?
10%
48
What are the most common complications of splenectomy?
infection and thrombosis
49
Why does giving thrombopoeitin work in ITP?
make lost of platelets to overwhelm the immune system
50
How do TPO-RAs work?
promote megakaryocyte and platelet development through the same way as endogenous TPO
51
What pathway does TPO work thtough?
Jak-Stat: same as cytokines
52
What receptor does TPO act upon?
c-Mpl
53
What is the MOA of eltrombopag?
is a TPO receptor agonist which targets the transmembrane part of the receptro
54
What is the efficacy of romiplostin?
70-90% response rates
55
How may TPO-RAs induce tolerance?
increased platelets allows reconstitution of Treg population
56
What further research is needed in ITP?
trials comparing second line treatments are needed
57
Why is destruction of T cells effective in antibody mediated diseases?
prevention of B cell stimulation
58
What is ITP characterised by?
isolated thrombocytopenia
59
What are the immunological causes of ITP?
pathogenic anti-platelet autoantibodies; T cell mediated platelet destruction and impaired megakaryocytes
60
What is the contributions of primary and secondary ITP ?
primary-80%
61
What are the symptoms of ITP?
petechiae; purpura; mucosal bleeding in GU/GI or oral tracts
62
What suggests taht a functional deficit of TPO is present in patietns with ITP?
2/3rds of patients with ITP have a normal or decreased TPO plasma level
63
What morphological abnormalities have been seen in megakaryocytes in ITP?
apoptotic ultrastructure and activation of aspase 3
64
What cytokines are raised in ITP?
IL-17; IL-2 and IFNy
65
Where does phagocytic breakdown of platelts occur in ITP?
spleen or liver
66
What suggestst that platelets undergo protein degradation by APCs followed by antigen presentation to T cells?
there have been other antibody specificities other than classic surface glycoproteins such as cytosolic proteins
67
What is the effect of oxidative stress in the context of autoimmunty?
favours the production of autoantibodies
68
Why does the presence of antiplatelet autoantibodies increase the risk of thrombotic events?
perhaps due to procoagulant microparticles released by activated platelets
69
How is BAFF related to ITP?
higher levels in patietns with ITP, promoter region polymorphisms are associated stronly
70
What may be responsible for the reduced FOXp3 numbers in patients with ITP?
CD3+ T cells have a lower rate of apoptosis and higher clonal expansion rate leading to increased type 1 cytokines ; dysregulated cellular immunity; increased CD16+ monocytes seen in ITP which release IL-12 promoting Th1 and inhibits Th17 downregulating Tregs ; reduced IDO from Dcs
71
What may cause the Th1/Th2 imbalance seen in ITP?
mediated by reduced secretion of platelet-derived chemokines and cytokiens
72
What supports the role of pDCs in ITP pathology?
platelet counts in ITP are highly correlated with the number of circulating pDCs (lower)
73
What shows teh impaired development of MKs in ITP?
decreased ploidy and granularity
74
What is the effect of autoantibodies on MK cells in itp?
approx 2/3rds of pts have antibodies that are able to significantly inhibit MK maturation from TPO-treated CD34 HSCs and induce apoptosis in vitro
75
How are MKs involvedi n the regulation of the immune system?
regulate other cells in the BM niche invluding plasma cells and inhibition of T cell activation and production of IL-10
76
Who tends to get the chronic version of ITP?
adults
77
What are the first line treatments for ITP?
steroids wtih or without IVIg and anti-D
78
What are the second line therapies for ITP | ?
splenectomy or rituximab
79
What is the effect of steroids in ITP?
increase Tregs; restore Th1/Th2 ratio; decrease BAFF to reduce B ells